Literature DB >> 17586502

Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region.

Barbara P Craddock1, Christopher Cotter, W Todd Miller.   

Abstract

The juxtamembrane (JM) regions of several receptor tyrosine kinases are involved in autoinhibitory interactions that maintain the low basal activity of the receptors; mutations can give rise to constitutive kinase activity and signaling. In this report, we show that the JM region of the human insulin-like growth factor I receptor (IGF1R) plays a role in kinase regulation. We mutated JM residues that were conserved in this subfamily of receptor tyrosine kinases, and expressed and purified the cytoplasmic domains using the Sf9/baculovirus system. We show that a kinase-proximal mutation (Y957F) and (to a lesser extent) a mutation in the central part of the JM region (N947A) increase the autophosphorylation activity of the kinase. Steady-state kinetic measurements show the mutations cause an increase in V(max) for phosphorylation of peptide substrates. When the holoreceptors were expressed in fibroblasts derived from IGF1R-deficient mice, the Y957F mutation led to a large increase in basal and in IGF1-stimulated receptor autophosphorylation. Together, these data demonstrate that the JM region of IGF1R plays an important role in limiting the basal activity of the receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586502      PMCID: PMC1986766          DOI: 10.1016/j.febslet.2007.06.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.

Authors:  S R Hubbard
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

Review 2.  Molecular and cellular aspects of the insulin-like growth factor I receptor.

Authors:  D LeRoith; H Werner; D Beitner-Johnson; C T Roberts
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

3.  The IGF-I receptor in cell growth, transformation and apoptosis.

Authors:  R Baserga; A Hongo; M Rubini; M Prisco; B Valentinis
Journal:  Biochim Biophys Acta       Date:  1997-06-07

4.  Stat5 is a physiological substrate of the insulin receptor.

Authors:  J Chen; H B Sadowski; R A Kohanski; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

5.  Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process.

Authors:  S C Barker; D B Kassel; D Weigl; X Huang; M A Luther; W B Knight
Journal:  Biochemistry       Date:  1995-11-14       Impact factor: 3.162

6.  Role of enzyme-peptide substrate backbone hydrogen bonding in determining protein kinase substrate specificities.

Authors:  N E Thomas; H N Bramson; W T Miller; E T Kaiser
Journal:  Biochemistry       Date:  1987-07-14       Impact factor: 3.162

7.  Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase.

Authors:  Clifford D Mol; Douglas R Dougan; Thomas R Schneider; Robert J Skene; Michelle L Kraus; Daniel N Scheibe; Gyorgy P Snell; Hua Zou; Bi-Ching Sang; Keith P Wilson
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

8.  Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.

Authors:  H Kato; T N Faria; B Stannard; C T Roberts; D LeRoith
Journal:  Mol Endocrinol       Date:  1994-01

9.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.

Authors:  T A Gustafson; W He; A Craparo; C D Schaub; T J O'Neill
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

10.  Amino acid sequences Gly-Pro-Leu-Tyr and Asn-Pro-Glu-Tyr in the submembranous domain of the insulin receptor are required for normal endocytosis.

Authors:  M Rajagopalan; J L Neidigh; D A McClain
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  6 in total

1.  The insulin and IGF1 receptor kinase domains are functional dimers in the activated state.

Authors:  M Zulema Cabail; Shiqing Li; Eric Lemmon; Mark E Bowen; Stevan R Hubbard; W Todd Miller
Journal:  Nat Commun       Date:  2015-03-11       Impact factor: 14.919

2.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

3.  Landmarks in insulin research.

Authors:  Colin W Ward; Michael C Lawrence
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-22       Impact factor: 5.555

4.  Effects of somatic mutations in the C-terminus of insulin-like growth factor 1 receptor on activity and signaling.

Authors:  Barbara P Craddock; W Todd Miller
Journal:  J Signal Transduct       Date:  2012-06-14

5.  How IGF-1 activates its receptor.

Authors:  Jennifer M Kavran; Jacqueline M McCabe; Patrick O Byrne; Mary Katherine Connacher; Zhihong Wang; Alexander Ramek; Sarvenaz Sarabipour; Yibing Shan; David E Shaw; Kalina Hristova; Philip A Cole; Daniel J Leahy
Journal:  Elife       Date:  2014-09-25       Impact factor: 8.140

6.  Two-step release of kinase autoinhibition in discoidin domain receptor 1.

Authors:  Douglas Sammon; Erhard Hohenester; Birgit Leitinger
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.